Mergers & Acquisitions Mergers & Acquisitions

Comment: Amazon-One Medical deal likely to fuel opposition based on novel theories of harm, but ultimately succeed

By Curtis Eichelberger and Serafina Smith
  • 28 Jul 2022 19:18
  • 28 Jul 2022 19:18
Amazon’s proposed acquisition of One Medical is likely to lead to great teeth-gnashing and consideration of novel theories of harm, but a successful lawsuit blocking the deal probably isn’t in the cards.

Amazon, the e-commerce giant known for offering millions of products on its platform with free two-day delivery, already has a smal

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Serafina Smith

Reporter


Serafina Smith covers mergers and acquisitions for MLex from New York. Before becoming a journalist, Serafina was a paralegal supporting the United States Department of Justice, where she worked on foreign bribery and money laundering cases. She holds a master’s degree in journalism from New York University and a bachelor’s degree in linguistics from Georgetown University.

Discover MLex

Stay on top of global regulatory developments

Latest News